Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Short Interest Up 30.5% in September

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) saw a significant increase in short interest in September. As of September 15th, there was short interest totalling 997,700 shares, an increase of 30.5% from the August 31st total of 764,600 shares. Based on an average daily trading volume, of 328,600 shares, the short-interest ratio is currently 3.0 days. Approximately 1.8% of the company’s shares are sold short.

Aveanna Healthcare Price Performance

AVAH stock traded down $0.16 during trading on Friday, hitting $5.17. 330,571 shares of the stock traded hands, compared to its average volume of 177,866. The stock has a market cap of $999.00 million, a price-to-earnings ratio of -8.62 and a beta of 2.13. Aveanna Healthcare has a 1 year low of $0.85 and a 1 year high of $5.95. The firm’s 50 day moving average is $4.96 and its two-hundred day moving average is $3.41.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($0.01) EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.03. The firm had revenue of $504.96 million for the quarter, compared to analysts’ expectations of $494.02 million. As a group, analysts anticipate that Aveanna Healthcare will post -0.09 EPS for the current fiscal year.

Institutional Trading of Aveanna Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of AVAH. Acadian Asset Management LLC boosted its position in shares of Aveanna Healthcare by 185.6% during the first quarter. Acadian Asset Management LLC now owns 29,385 shares of the company’s stock valued at $72,000 after buying an additional 19,096 shares during the last quarter. Mackenzie Financial Corp grew its stake in shares of Aveanna Healthcare by 35.9% during the 2nd quarter. Mackenzie Financial Corp now owns 45,674 shares of the company’s stock valued at $126,000 after purchasing an additional 12,075 shares during the period. Bank of New York Mellon Corp increased its position in shares of Aveanna Healthcare by 6.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock valued at $413,000 after purchasing an additional 9,243 shares during the last quarter. Renaissance Technologies LLC lifted its stake in shares of Aveanna Healthcare by 155.8% in the 2nd quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock worth $438,000 after purchasing an additional 96,600 shares during the period. Finally, Vanguard Group Inc. boosted its holdings in shares of Aveanna Healthcare by 1.8% in the first quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock worth $6,402,000 after buying an additional 44,970 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Royal Bank of Canada lifted their price objective on Aveanna Healthcare from $3.00 to $5.00 and gave the company a “sector perform” rating in a research report on Friday, August 9th. Deutsche Bank Aktiengesellschaft raised their price objective on Aveanna Healthcare from $3.00 to $5.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Finally, UBS Group upped their target price on shares of Aveanna Healthcare from $1.70 to $2.80 and gave the stock a “sell” rating in a research report on Friday, August 9th.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.